The techniques Theodore Biewer and his colleagues are using to measure whether plasma has the right conditions to create fusion have been around awhile.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.